> top > docs > PubMed:1981844 > annotations

PubMed:1981844 JSONTXT

Annnotations TAB JSON ListView MergeView

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 57-66 DNA denotes enhancers
T2 91-97 cell_type denotes T-cell
T3 366-383 DNA denotes sequence elements
T4 393-414 DNA denotes long terminal repeats
T5 416-420 DNA denotes LTRs
T6 469-488 DNA denotes regulatory elements
T7 496-505 DNA denotes HIV-2 LTR
T8 511-520 DNA denotes HIV-2 LTR
T9 546-555 DNA denotes enhancers
T10 570-579 DNA denotes enhancers
T11 610-624 DNA denotes HIV-1 enhancer
T12 631-639 DNA denotes enhancer
T13 656-690 DNA denotes T-cell activation response element
T14 721-736 DNA denotes second enhancer
T15 824-832 DNA denotes enhancer
T16 852-876 protein denotes nuclear binding proteins

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-109 Sentence denotes Human immunodeficiency virus type-2 gene expression: two enhancers and their activation by T-cell activators.
S2 110-299 Sentence denotes The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying potential to infect their host, undergo long periods of latent infection, and induce pathology.
S3 300-506 Sentence denotes Since expression of the viruses is in large part regulated by the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR.
S4 507-556 Sentence denotes The HIV-2 LTR was found to contain two enhancers.
S5 557-625 Sentence denotes One of these enhancers is, in part, identical to the HIV-1 enhancer.
S6 626-812 Sentence denotes This enhancer in HIV-1 is the T-cell activation response element; in HIV-2, however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators.
S7 813-976 Sentence denotes The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation.
S8 977-1202 Sentence denotes Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 53-66 NP denotes two enhancers
C2 71-76 NP denotes their
C3 77-108 NP denotes activation by T-cell activators
C4 110-151 NP denotes The human immunodeficiency viruses (HIVs)
C5 164-190 NP denotes a spectrum of retroviruses
C6 224-229 NP denotes their
C7 320-331 NP denotes the viruses
C8 387-392 NP denotes their
C9 492-505 NP denotes the HIV-2 LTR
C10 507-520 NP denotes The HIV-2 LTR
C11 542-555 NP denotes two enhancers
C12 606-624 NP denotes the HIV-1 enhancer
C14 626-639 NP denotes This enhancer
C13 626-648 NP denotes This enhancer in HIV-1
C15 695-700 NP denotes HIV-2
C16 711-713 NP denotes it
C17 717-736 NP denotes the second enhancer
C18 737-741 NP denotes that
C19 768-811 NP denotes activation in response to T-cell activators
C20 813-832 NP denotes The second enhancer
C21 848-903 NP denotes two nuclear binding proteins (85 kD and 27 kD mobility)
C22 904-908 NP denotes that
C23 1014-1029 NP denotes the speculation
C24 1030-1034 NP denotes that
C25 1070-1114 NP denotes the regulation of HIV-1 and HIV-2 expression
C26 1115-1119 NP denotes that
C27 1196-1201 NP denotes HIV-2
R1 C2 C1 coref-pron their,two enhancers
R2 C6 C5 coref-pron their,a spectrum of retroviruses
R3 C7 C4 coref-ident the viruses,The human immunodeficiency viruses (HIVs)
R4 C8 C7 coref-pron their,the viruses
R5 C10 C9 coref-ident The HIV-2 LTR,the HIV-2 LTR
R6 C11 C1 coref-ident two enhancers,two enhancers
R7 C13 C12 coref-ident This enhancer in HIV-1,the HIV-1 enhancer
R8 C16 C14 coref-pron it,This enhancer
R9 C18 C17 coref-relat that,the second enhancer
R10 C19 C3 coref-ident activation in response to T-cell activators,activation by T-cell activators
R11 C20 C17 coref-ident The second enhancer,the second enhancer
R12 C22 C21 coref-relat that,two nuclear binding proteins (85 kD and 27 kD mobility)
R13 C24 C23 coref-relat that,the speculation
R14 C26 C25 coref-relat that,the regulation of HIV-1 and HIV-2 expression
R15 C27 C15 coref-ident HIV-2,HIV-2

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-28 virus denotes Human immunodeficiency virus
T2 57-66 DNA_domain_or_region denotes enhancers
T3 91-97 cell_type denotes T-cell
T4 114-144 virus denotes human immunodeficiency viruses
T5 146-150 virus denotes HIVs
T6 178-190 virus denotes retroviruses
T7 260-276 other_name denotes latent infection
T8 289-298 other_name denotes pathology
T9 366-383 DNA_domain_or_region denotes sequence elements
T10 393-414 DNA_domain_or_region denotes long terminal repeats
T11 416-420 DNA_domain_or_region denotes LTRs
T12 469-488 DNA_family_or_group denotes regulatory elements
T13 496-501 virus denotes HIV-2
T14 511-516 virus denotes HIV-2
T15 546-555 DNA_domain_or_region denotes enhancers
T16 570-579 DNA_domain_or_region denotes enhancers
T17 610-615 virus denotes HIV-1
T18 631-639 DNA_domain_or_region denotes enhancer
T19 643-648 virus denotes HIV-1
T20 656-673 other_name denotes T-cell activation
T21 695-700 virus denotes HIV-2
T22 721-736 DNA_domain_or_region denotes second enhancer
T23 794-811 other_name denotes T-cell activators
T24 824-832 DNA_domain_or_region denotes enhancer
T25 852-876 protein_family_or_group denotes nuclear binding proteins
T26 943-960 other_name denotes enhancer function
T27 1074-1084 other_name denotes regulation
T28 1088-1093 virus denotes HIV-1
T29 1098-1103 virus denotes HIV-2
T30 1159-1166 other_name denotes latency
T31 1196-1201 virus denotes HIV-2